Search results
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $143.00
ETF DAILY NEWS· 12 hours agoMerck & Co., Inc. (NYSE:MRK – Free Report) had its target price boosted by Truist Financial from $142.00 to $143.00 in a research report released on Friday ...
Merck reports promising V116 vaccine trial results By Investing.com
Investing.com· 3 hours agoMerck & Co. (NYSE: MRK) has presented new data from its Phase 3 STRIDE-10 trial of V116, an...
Here’s Why Merck & Co. (MRK) Outperformed in Q1
Insider Monkey via Yahoo Finance· 6 days agoBaron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be...
What Direction Does Merck & Co Inc (NYSE: MRK) Analysts Think The Company Will Take? – Stocks...
Stocks Register· 5 days agoThe trading price of Merck & Co Inc (NYSE:MRK) remained unchanged on Tuesday, April 23, closing at $126.88. The company’s P/E ratio in the trailing 12-month ...
Merck&Co earnings beat by $0.14, revenue topped estimates
Investing.com· 5 days agoMerck&Co earnings beat by $0.14, revenue topped estimates
Merck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Simply Wall St. via Yahoo Finance· 2 days agoMerck & Co., Inc. (NYSE:MRK) just released its quarterly report and things are looking bullish. The...
Merck Lifts FY24 Outlook After Higher Q1 Earnings, Above Market; Stock Up In Pre-market
RTT News· 4 days agoDrug major Merck & Co., Inc. (MRK), while reporting higher first-quarter earnings, above market estimates, on Thursday raised its fiscal 2024 adjusted earnings and sales view.
Merck jumps on profit beat as Bristol Myers Squibb slips to a loss
Proactive Investors· 4 days agoMerck & Co Inc (NYSE:MRK, ETR:6MK), the pharmaceutical firm, saw its shares tick 3.5% higher after...
Merck Raises Forecast as Sales of Its Cancer Immune Therapy Soar
Bloomberg· 4 days agoMerck & Co. raised its annual profit and revenue forecast as the blockbuster cancer drug Keytruda...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 4 days agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...